Login / Signup

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.

Amelie de GregorioLothar HäberlePeter A FaschingVolkmar MüllerIris SchraderRalf LorenzHelmut ForstbauerThomas W P FriedlEmanuel BauerNikolaus de GregorioMiriam DenizVisnja FinkInga BekesUlrich AndergassenAndreas SchneeweissHans TeschSven MahnerSara Y BruckerJens-Uwe BlohmerTanja N FehmGeorg HeinrichKrisztian LatoMatthias W BeckmannBrigitte RackWolfgang Janni
Published in: Breast cancer research : BCR (2020)
Clinicaltrials.gov NCT02181101 and EU Clinical Trials Register EudraCT 2005-000490-21. Registered September 2005.
Keyphrases
  • phase iii
  • early breast cancer
  • clinical trial
  • open label
  • phase ii
  • double blind
  • placebo controlled
  • study protocol
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer